Audit a URL →

Sign in Sign up free

Loading…

Weekly · Sunday Morning

Five longevity claims.
Worth your time.
Every Sunday.

Last Sunday

Rapamycin extends mouse lifespan 9–14%
NAD+ precursors reverse aging in humans
Blue-light glasses improve sleep quality
Walking 10 min after meals blunts glucose
Verdict change — caffeine half-life downgraded

5 audits·1 verdict change·0 affiliate links·Every Sunday

Joining 1,247 readers — founders, MDs, and longevity-obsessed people who fact-check their own health decisions.

Browse

Decisions Claims Content Creators

Product

Audit a URL Sunday roundup API (soon)Pricing

About

FAQ Methodology Editorial Standards Corrections Press & brand RSS feed

Legal

Terms of Service Privacy Policy DMCA

Finally, something serious in this space.
Because we actually read the papers.

© 2026 Whalespan. Independent, evidence-graded longevity.

Medicine 3.0: Rethinking Prostate Cancer Screening — Whalespan

Content›Video›Medicine 3.0: Rethinking Pro…

Medicine 3.0: Rethinking Prostate Cancer Screening

Peter Attia6m · 2025-05-24

Claims Made

12

Claims Supported

8

Support Rate

67%

Support rate

8 of 12 claims supported

8 supported4 partial / not

Claims from this content

11

✓Well SupportedPSA density is a predictor of prostate cancer diagnosis, aggressiveness, and patient outcome.✓Well SupportedFree PSA percentage, along with absolute PSA, PSA velocity, and PSA density, provides valuable information for assessing prostate cancer risk.◐Partially SupportedWith existing technology, people do not need to die of colorectal cancer and men do not need to die of prostate cancer.◐Partially SupportedProstate cancer is preventable due to its slow development and tools to predict lethality.Partially Supported

More from Peter Attia

Peter Attia on Zone 2 Cardio

Peter Attia on Rapamycin (with Matt Kaeberlein)

Attia walks back the clinic protocol: too aggressive for healthy adults

Discussion

Native comments, Twitter mentions, and Reddit threads about this content — surfaced together so the conversation isn't fragmented across platforms.

M

Share your read of this content…

Posting publicly as you · linked to your social profiles

Sort by:

AV

A. Volkovreader

4h

Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.

NP

N. Park

2d

Would love a "what would change this verdict" RSS feed. Sign me up if it exists.

◐

Additional tests like PHI or 4K can further elucidate risk if initial PSA-derived metrics are inconclusive.

◐Partially SupportedMultiparametric MRI is a potential gold standard test before proceeding to a biopsy for prostate cancer diagnosis.

◐Partially SupportedIndividuals should advocate for Medicine 3.0 principles and understand screening risks while remaining confident in tests like PSA and its derivatives.

✕Not SupportedMetastatic bone cancer is debilitating and represents an unacceptable outcome that could have been prevented with proactive screening and intervention.

✕Not SupportedMedicine 2.0's reliance on actuarial life expectancy data for older individuals can lead to under-treatment of slow-moving cancers, potentially prioritizing lifespan over healthspan.

◐Partially SupportedPSA alone can be a misleading biomarker, leading to false positives and false negatives.

◐Partially SupportedThe decision for men over 70 to undergo PSA screening is optional and should be based on patient-doctor discussion.